TAVI likely to be a cost-effective option for SAVR-ineligible patients with severe aortic stenosis

Authors
Publication date
Publisher
'Springer Science and Business Media LLC'
Doi

    Abstract

    Abstract is not available.

      Similar works

      Full text

      thumbnail-image

      Available Versions

      Crossref

      redirect
      oaiinfo:doi/10.1038%2Fnrcardio.20...
      Last time updated on 29/11/2020